Concepedia

Nathan R. Miselis

NR

8

Publications

601

Citations

8

H-Index

1997

Active since

Affiliations

Harvard University(Current)

Massachusetts General Hospital

Merck & Co., Inc., Rahway, NJ, USA (United States)

Brown University

Nathan R. Miselis is an author at Harvard University specializing in cell biology, medicine, and molecular biology.

Top concepts

Publications per year

1997–2018

8

Publications

8

Development of MK-8353, an orally administered ERK1/2 inhibitor, in patients with advanced solid tumors

Stergios J. Moschos, Ryan J. Sullivan, Wen-Jen Hwu et al. · JCI Insight · 2018 · 145 citations · Full text

Targeting tumor-associated macrophages in an orthotopic murine model of diffuse malignant mesothelioma

Nathan R. Miselis, Zhijin Wu, Nico van Rooijen et al. · Molecular Cancer Therapeutics · 2008 · 106 citations · Full text

Homologous and Nonhomologous Recombination Resulting in Deletion: Effects of p53 Status, Microhomology, and Repetitive DNA Length and Orientation

Dan Gebow, Nathan R. Miselis, Howard L. Liber · Molecular and Cellular Biology · 2000 · 98 citations · Full text

Unique functions of CHK1 and WEE1 underlie synergistic anti-tumor activity upon pharmacologic inhibition

Amy D. Guertin, Melissa M. Martin, Brian S. Roberts et al. · Cancer Cell International · 2012 · 82 citations · Full text

Efficient Repair of All Types of Single-Base Mismatches in Recombination Intermediates in Chinese Hamster Ovary Cells: Competition Between Long-Patch and G-T Glycosylase-Mediated Repair of G-T Mismatches

Colin A. Bill, Walter Duran, Nathan R. Miselis et al. · Genetics · 1998 · 57 citations · Full text

, , +15

Rows per page

1–5 of 8